The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 29, 2016
Filed:
Sep. 06, 2012
Applicant:
Richard C. K. Yen, Yorba Linda, CA (US);
Inventor:
Richard C. K. Yen, Yorba Linda, CA (US);
Assignee:
Other;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 38/16 (2006.01); A61K 31/4709 (2006.01); A61K 35/18 (2015.01); A61K 35/14 (2015.01); A61P 7/04 (2006.01); A61K 38/36 (2006.01); A61P 7/00 (2006.01); A61P 31/00 (2006.01); A61P 33/06 (2006.01); A61P 39/06 (2006.01); A61K 9/14 (2006.01); A61K 35/16 (2015.01); A61K 9/00 (2006.01); A61K 9/50 (2006.01); A61K 9/51 (2006.01); A61K 9/10 (2006.01);
U.S. Cl.
CPC ...
A61K 9/0019 (2013.01); A61K 9/5052 (2013.01); A61K 9/5169 (2013.01); A61K 38/363 (2013.01); A61K 9/10 (2013.01);
Abstract
A method of treating a patient who has extravasation of blood from an intravascular compartment to an extravascular compartment. An agent is administered to the patient which mitigates a harmful effect of break-down products of blood at an extravascular site, resulting in the patient having reduced morbidity and mortality. The morbidity and mortality of the patient is further reduced by concomitant administration of a suspension of submicron protein spheres having a molecular weight of ranging from 780 billion Daltons to less than 0.8 billion Daltons.